Term ends May 30, 2038 · Low confidence
20-year base term ends May 30, 2038
May 30, 2018
May 30, 2038
Dec 29, 2020
This patent's term runs 4 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 30, 2018, when application 15/992,336, the earliest non-provisional in its chain, was filed (this one was filed Mar 13, 2020); a parent in its chain could not be resolved (the next row) | May 30, 2038 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +4 days, USPTO patent term adjustment record | Jun 3, 2038 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,251,873, US 10,471,053, US 10,792,278, US 10,792,279, US 10,799,491, US 10,806,727, US 10,849,889, US 10,849,890, US 10,857,141, US 10,857,142, US 10,874,655, US 10,874,657) | capped to May 30, 2038 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 16678183 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | May 30, 2038 | Low confidence |
This family
| US 10,251,873 | In force May 2038 | May 2038 |
| US 10,471,053 | In force May 2038 | May 2038 |
| US 10,874,655 | In force May 2038 | May 2038 |
| US 10,849,889 | In force May 2038 | May 2038 |
| US 10,857,141 | In force May 2038 | May 2038 |
| US 10,874,656 | this patent May 2038 | May 2038 |
| US 10,874,657 | In force May 2038 | May 2038 |
| US 10,857,142 | In force May 2038 | May 2038 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 11, 2020 Reel 52625, frame 916 | Amicus Therapeutics, Inc. | Biopharma Credit PLC | Security Interest |
| May 21, 2020 Reel 52741, frame 173 | Biopharma Credit PLC | BPCR Limited Partnership | Omnibus Confirmation of Assignment Agreement |
| Jul 30, 2020 Reel 53360, frame 659 | BPCR Limited Partnership | Amicus Therapeutics, Inc. | Release of Security Interest |
| Jul 30, 2020 Reel 53365, frame 342 | Amicus Therapeutics, Inc. | Hayfin Services LLP, as Agent | Security Interest |
| Aug 5, 2022 Reel 61099, frame 803 | Castelli, Jeff; Benjamin, Elfrida | Amicus Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 6, 2023 Reel 65177, frame 196 | Amicus Therapeutics, Inc. | Wilmington Trust, National Association | Security Interest |
| Oct 6, 2023 Reel 65164, frame 945 | Hayfin Services LLP | Amicus Therapeutics, Inc. | Release of Security Interest |
| Apr 27, 2026 Reel 75493, frame 968 | Biomarin Pharmaceutical Inc.; Amicus Therapeutics, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
| Apr 27, 2026 Reel 75494, frame 30 | Wilmington Trust, National Association | Amicus Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,251,873, US 10,471,053, US 10,792,278, US 10,792,279, US 10,799,491, US 10,806,727, US 10,849,889, US 10,849,890, US 10,857,141, US 10,857,142, US 10,874,655, US 10,874,657.